Last reviewed · How we verify
NCT03957772: SUPRA
The Efficacy of Extra- Versus Intrafascial Injection for Supraclavicular Brachial Plexus Block
Phase 4 trial testing Extrafascial injection in Upper Extremity Problem in 50 participants. Completed in 30 April 2021.
30 April 2021
Quick facts
| Lead sponsor | Hôpital du Valais |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 January 2020 |
| Primary completion | 30 April 2021 |
| Estimated completion | 30 April 2021 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Extrafascial injection
- Intrafascial injection
Conditions studied
- Upper Extremity Problem — all drugs for Upper Extremity Problem →
Sponsor
Hôpital du Valais — full company profile →
Who can join
Adults 18 to 85, any sex, with Upper Extremity Problem. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients will be randomized to one of two groups: 1. Extrafascial injection group: Ultrasound-guided supraclavicular brachial plexus block with 2 injections of local anaesthetic, deposited at the exterior of the fascial sheath that surrounds the nerves 2. Intrafascial injection group: Ultrasound-guided supraclavicular brachial plexus block with 2 injections of local anaesthetic, deposited at the interior of the fascial sheath that surrounds the nerves
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of an extrafascial versus intrafascial injection for supraclavicular brachial plexus block on respiratory function: a randomized, controlled, double-blind trial.
Grape S, Kirkham K, Zemirline N, Bikfalvi A, et al · · 2022 · cited 2× · PMID 35777931 · DOI 10.1136/rapm-2022-103634
Verify or expand the search:
- PubMed search for NCT03957772
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Upper Extremity Problem
Currently open trials in the same condition.
- NCT07026084 — Effects of Biofeedback-Guided Training on Muscle Strength and Postural Alignment in Upper Cross Syndrome. · NA · recruiting
- NCT06349434 — The Utilization Effects of Powered Wearable Orthotics in Improving Upper Extremity Function and ADL in Persons With SCI · NA · recruiting
- NCT05691023 — VNS-REHAB At-Home - Post-Market Study for Using the Vivistim System® at Home · active not recruiting
- NCT05301140 — Vivistim Registry for Paired VNS Therapy (GRASP) · recruiting
Other Hôpital du Valais trials
Trials by the same sponsor.
- NCT07527468 — HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery · NA · not yet recruiting
- NCT06239025 — Efficacy of Transversus Thoracis Muscle Plane Block in Patients Undergoing Cardiac Surgery · Phase 4 · completed
- NCT06439511 — Comparison of a Non Contact Vital Signs Application With Traditional Pulse Oximetry for Heart Rate Measurement · NA · completed
- NCT05389852 — Analgesic Efficacy of Intravenous Dexmedetomidine for Supraclavicular Plexus Block · Phase 4 · completed
- NCT04250649 — Does Disinfection of the Subcutaneous Tissue Reduce Contamination of the Operating Field With P. Acnes? · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03957772 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hôpital du Valais
- Last refreshed: 18 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03957772.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing